Avience Biomedi.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0V9I01017
  • NSEID: AVIENCE
  • BSEID:
INR
246.05
-1.95 (-0.79%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 21000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

21.0 k (43.44%) Volume

Shareholding (Jun 2026)

FII

3.06%

Held by 20 FIIs

DII

9.08%

Held by 4 DIIs

Promoter

64.59%

Why is Avience Biomedi. falling/rising?

09-Aug-2026

As of 08-Aug, Avience Biomedicals Ltd's stock price is at 246.05, down 1.95 (-0.79%), reflecting a significant decline of 4.26% over the past week and 15.42% over the past month, while the Sensex has gained. The stock is trading below its moving averages, indicating a bearish trend and reduced investor interest.

As of 08-Aug, Avience Biomedicals Ltd's stock price is falling, currently at 246.05, reflecting a decrease of 1.95 (-0.79%). The stock has shown a significant decline over the past week, with a drop of 4.26%, while the benchmark Sensex has increased by 0.77% during the same period. Over the past month, the stock has decreased by 15.42%, contrasting with a modest gain of 0.70% in the Sensex.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. There has also been a notable decline in investor participation, with delivery volume dropping by 28.57% compared to the 5-day average, suggesting reduced interest from investors. Overall, these factors contribute to the downward movement of Avience Biomedicals Ltd's stock price.

View full answer

Which are the latest news on Avience Biomedi.?

09-Aug-2026
No latest news for Avience Biomedi. found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 136 Cr (Micro Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

102

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.83

stock-summary
Return on Equity

27.86%

stock-summary
Price to Book

4.33

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
8.16
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.94
Tax Ratio
29.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.15%
ROCE (avg)
25.12%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.30
EV to EBIT
11.73
EV to EBITDA
10.77
EV to Capital Employed
2.80
EV to Sales
3.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.89%
ROE (Latest)
27.86%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.25%)

FIIs

Held by 20 FIIs (3.06%)

Promoter with highest holding

Dharm Deo Choudhary (37.17%)

Highest Public shareholder

Sanshi Fund-i (2.64%)

Individual Investors Holdings

13.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Avience Biomedi."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.07",
          "val2": "15.26",
          "chgp": "5.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.53",
          "val2": "4.33",
          "chgp": "27.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.37",
          "val2": "0.25",
          "chgp": "48.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.19",
          "val2": "3.02",
          "chgp": "5.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.41%",
          "val2": "28.37%",
          "chgp": "6.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Avience Biomedi."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 22.22% vs 77.68% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 34.60% vs 150.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.31",
          "val2": "28.89",
          "chgp": "22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.90",
          "val2": "7.65",
          "chgp": "42.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.62",
          "val2": "0.61",
          "chgp": "1.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.08",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.73",
          "val2": "5.00",
          "chgp": "34.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.87%",
          "val2": "26.48%",
          "chgp": "4.39%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
16.07
15.26
5.31%
Operating Profit (PBDIT) excl Other Income
5.53
4.33
27.71%
Interest
0.37
0.25
48.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.19
3.02
5.63%
Operating Profit Margin (Excl OI)
34.41%
28.37%
6.04%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
35.31
28.89
22.22%
Operating Profit (PBDIT) excl Other Income
10.90
7.65
42.48%
Interest
0.62
0.61
1.64%
Exceptional Items
0.00
-0.08
100.00%
Standalone Net Profit
6.73
5.00
34.60%
Operating Profit Margin (Excl OI)
30.87%
26.48%
4.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 22.22% vs 77.68% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 34.60% vs 150.00% in Mar 2025

stock-summaryCompany CV
About Avience Biomedicals Ltd stock-summary
stock-summary
Avience Biomedicals Ltd
Micro Cap
Healthcare Services
Avience Biomedicals Limited was originally incorporated as Private Limited Company as "Avience Biomedicals Private Limited" on December 23, 2019 with the Registrar of Companies, Delhi. Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to "Avience Biomedicals Limited" and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi.
Company Coordinates stock-summary
Icon
No Company Details Available